Inhibition of thromboxane biosynthesis in serum: Limitations of the measurement of immunoreactive 6-KETO-PGF1α
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 33 (1) , 99-103
- https://doi.org/10.1016/0049-3848(84)90159-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.Journal of Clinical Investigation, 1983
- SELECTIVE INHIBITION OF THROMBOXANE SYNTHETASE BY DAZOXIBEN INCREASES PROSTACYCLIN PRODUCTION BY LEUCOCYTES IN ANGINA PATIENTS AND HEALTHY VOLUNTEERSThe Lancet, 1982
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Prostacyclin is not a circulating hormone in manProstaglandins, 1982
- Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditionsBlood, 1981
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Analysis of Melatonin in Human Plasma by Gas Chromatography Negative Chemical Ionization Mass SpectrometryScience, 1978
- A radioimmunoassay for thromboxane B2Analytical Biochemistry, 1977
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975